VALSARTAN / AMLODIPINE (Exforge®)
Clinical Indication
Hypertension
Comments
Not approved by local committee
Date of classification
March 2017
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.